DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/n2k293/global_cystic) has announced the addition of the "Global Cystic Fibrosis Pipeline Capsule - 2013" report to their offering.
Fore Pharma's latest report Global Cystic Fibrosis Pipeline Capsule - 2013' provides up-to-date information on key Research and Development (R&D) activities in the global cystic fibrosis market. It covers active cystic fibrosis pipeline molecules in clinical trials, preclinical research, and drug discovery.
This report helps executives track competitor pipeline molecules. The pipeline data presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.
The scope of the report includes information on cystic fibrosis pipeline molecules by clinical trial stages, company, mechanism of action, and country (The US, Germany, France, Italy, Spain, UK, Japan, and Rest of the World). Cystic fibrosis pipeline molecules licensing activities are also covered in this report.
Key Topics Covered:
1. Cystic Fibrosis - Disease Overview
2. Cystic Fibrosis Pipeline Overview
3. Cystic Fibrosis Pipeline by Geography
3a. Cystic Fibrosis Pipeline in Matured Markets
4. Cystic Fibrosis Phase 3 Clinical Trial Pipeline Insights
4a. Cystic Fibrosis Phase 3 Clinical Trial Pipeline (North America)
4b. Cystic Fibrosis Phase 3 Clinical Trial Pipeline (Europe)
4c. Cystic Fibrosis Phase 3 Clinical Trial Pipeline (ROW)
5. Cystic Fibrosis Phase 2 Clinical Trial Pipeline Insights
5a. Cystic Fibrosis Phase 2 Clinical Trial Pipeline (North America)
5b. Cystic Fibrosis Phase 2 Clinical Trial Pipeline (Europe)
5c. Cystic Fibrosis Phase 2 Clinical Trial Pipeline (ROW)
6. Cystic Fibrosis Phase 1 Clinical Trial Pipeline Insights
6a. Cystic Fibrosis Phase 1 Clinical Trial Pipeline (North America)
6b. Cystic Fibrosis Phase 1 Clinical Trial Pipeline (Europe)
6c. Cystic Fibrosis Phase 1 Clinical Trial Pipeline (ROW)
7. Cystic Fibrosis Preclinical Research Pipeline Insights
7a. Cystic Fibrosis Preclinical Research Pipeline (North America)
7b. Cystic Fibrosis Preclinical Research Pipeline (Europe)
7c. Cystic Fibrosis Preclinical Research Pipeline (ROW)
8. Cystic Fibrosis Drug Discovery Pipeline Insights
8a. Cystic Fibrosis Drug Discovery Pipeline (North America)
8b. Cystic Fibrosis Drug Discovery Pipeline (Europe)
8c. Cystic Fibrosis Drug Discovery Pipeline (ROW)
9. Cystic Fibrosis Market - Licensing Activities
10. Appendix
11. Research Methodology
For more information visit http://www.researchandmarkets.com/research/n2k293/global_cystic
